Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562

T L Holyoake, E K Allan, J C Mountford, L Richmond, S J Harrison, M A Elliott, H G Jorgensen

Research output: Contribution to journalConference Contribution

Abstract

Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.
LanguageEnglish
Article number2420
Pages654A-654A
Number of pages1
JournalBlood
Volume102
Issue number11
Publication statusPublished - 16 Nov 2003
Event45th Annual Meeting of the American-Society-of-Hematology - San Diego, United States
Duration: 6 Dec 20039 Dec 2003

Fingerprint

Bryostatins
Cells
Cell Line
Imatinib Mesylate

Keywords

  • pre-treatment
  • bryostatin
  • lonafirnib
  • efficacy
  • imatinib
  • G0/G1
  • ph+ cell line

Cite this

Holyoake, T. L., Allan, E. K., Mountford, J. C., Richmond, L., Harrison, S. J., Elliott, M. A., & Jorgensen, H. G. (2003). Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562. Blood, 102(11), 654A-654A. [2420].
Holyoake, T L ; Allan, E K ; Mountford, J C ; Richmond, L ; Harrison, S J ; Elliott, M A ; Jorgensen, H G . / Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562. In: Blood. 2003 ; Vol. 102, No. 11. pp. 654A-654A.
@article{cef53677acd545828822d2d3800fdafe,
title = "Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562",
abstract = "Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.",
keywords = "pre-treatment, bryostatin, lonafirnib, efficacy, imatinib , G0/G1, ph+ cell line",
author = "Holyoake, {T L} and Allan, {E K} and Mountford, {J C} and L Richmond and Harrison, {S J} and Elliott, {M A} and Jorgensen, {H G}",
year = "2003",
month = "11",
day = "16",
language = "English",
volume = "102",
pages = "654A--654A",
journal = "Blood",
issn = "0006-4971",
number = "11",

}

Holyoake, TL, Allan, EK, Mountford, JC, Richmond, L, Harrison, SJ, Elliott, MA & Jorgensen, HG 2003, 'Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562' Blood, vol. 102, no. 11, 2420, pp. 654A-654A.

Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562. / Holyoake, T L ; Allan, E K ; Mountford, J C ; Richmond, L ; Harrison, S J ; Elliott, M A ; Jorgensen, H G .

In: Blood, Vol. 102, No. 11, 2420, 16.11.2003, p. 654A-654A.

Research output: Contribution to journalConference Contribution

TY - JOUR

T1 - Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562

AU - Holyoake, T L

AU - Allan, E K

AU - Mountford, J C

AU - Richmond, L

AU - Harrison, S J

AU - Elliott, M A

AU - Jorgensen, H G

PY - 2003/11/16

Y1 - 2003/11/16

N2 - Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.

AB - Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.

KW - pre-treatment

KW - bryostatin

KW - lonafirnib

KW - efficacy

KW - imatinib

KW - G0/G1

KW - ph+ cell line

M3 - Conference Contribution

VL - 102

SP - 654A-654A

JO - Blood

T2 - Blood

JF - Blood

SN - 0006-4971

IS - 11

M1 - 2420

ER -

Holyoake TL, Allan EK, Mountford JC, Richmond L, Harrison SJ, Elliott MA et al. Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562. Blood. 2003 Nov 16;102(11):654A-654A. 2420.